Circulating soluble endoglin modifies the inflammatory response in mice.

Area of Science:

• Biomedical Science
• Immunology
• Cardiovascular Research

Background:

• Inflammation is a key factor in many diseases, including cardiovascular conditions.
• Elevated soluble endoglin levels are observed in cardiovascular disease patients with inflammation.

Purpose of the Study:

• To investigate the role of circulating soluble endoglin in the inflammatory response.
• To assess the potential of soluble endoglin as a therapeutic target for inflammatory diseases.

Main Methods:

• Utilized transgenic mice expressing human soluble endoglin (sEng+).
• Induced inflammation in lung and kidney tissues using three different models.
• Quantified leukocyte infiltration, inflammatory cytokines, adhesion molecules, and vascular permeability.

Main Results:

• sEng+ mice showed reduced lung and kidney injury and neutrophil infiltration compared to wild-type mice.
• Soluble endoglin significantly decreased pro-inflammatory cytokines (TNFα, IL1β, IL6).
• It also reduced inflammatory-induced adhesion molecules (ICAM, VCAM, E-selectin) and vascular permeability.

Conclusions:

• Soluble endoglin plays a protective role by modulating inflammatory responses.
• These findings suggest soluble endoglin's potential in treating inflammatory and cardiovascular diseases.